Assoc ProfessorVirginie Gautier

Dr Virginie Gautier is Associate Professor in Virology and Principal Investigator in UCD Centre for Experimental Pathogen Host Research (CEPHR).
She leads several translational research projects on various risk group 3 emerging pathogens including HIV, SARS-CoV-2 and MPOX virus with a specific interest for host-virus interface. She leads several translational research programme on risk group 3 emerging pathogens including HIV-1, SARS-CoV-2, MPXV or pathogen Y/X, with a specific interest for host-virus interface. Her Group core expertise lies in Cellular Biology, Molecular Virology, Epigenetics, Functional Genomics, drugs-screening assay, and pre-clinical assays. Her research programmes receive funding from various sources, including the Health Research Board (HRB), Science Foundation Ireland (SFI), Irish Research Council (IRC), and the European Union.

Dr Virginie Gautier is the head of virology programmes at the UCD Centre for Experimental Pathogen Host Research (CEPHR). She oversees the management and training of the Research Division at the Containment Level 3 (CL3) facility, which supports research involving Risk Group 3 Biological Agents. This state-of-the-art infrastructure is crucial for advancing research in translational infectious diseases and is a vital resource for Ireland's preparedness against future viral outbreaks and pandemic readiness.

Dr Gautier is actively involved in Public engagement and OUTREACH activities working with primary and secondary schools and key stakeholders. She was recently invited to give a TEDxUCD Talk entitled ' HIV CURE: What lies beneath' where she shares her insights on our HIV CURE research (https://www.youtube.com/watch?v=Wvx297drKmk)